Adage Capital Partners’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.2M | Buy |
+4,839,000
| New | +$11.2M | 0.02% | 592 |
|
|
2025
Q1 | – | Sell |
-5,000,000
| Closed | -$8.65M | – | 944 |
|
|
2024
Q4 | $8.65M | Buy |
+5,000,000
| New | +$8.65M | 0.02% | 642 |
|
|
2024
Q2 | – | Sell |
-220,000
| Closed | -$631K | – | 937 |
|
|
2024
Q1 | $631K | Sell |
220,000
-200,000
| -48% | -$574K | ﹤0.01% | 800 |
|
|
2023
Q4 | $743K | Sell |
420,000
-1,080,000
| -72% | -$1.91M | ﹤0.01% | 771 |
|
|
2023
Q3 | $4.74M | Buy |
+1,500,000
| New | +$4.74M | 0.01% | 670 |
|